Read More 1 minute read Analyst Ratings News Price Target Reiteration Wedbush Reiterates Outperform on Chipotle Mexican Grill, Maintains $2080 Price Target By Benzinga Newsdesk March 17, 8:25 AM Wedbush analyst Nick Setyan reiterates Chipotle Mexican Grill (NYSE:CMG) with a Outperform and maintains $2080 price target. CMG
Read More 1 minute read Analyst Ratings News Price Target Reiteration Wedbush Reiterates Outperform on Geron, Maintains $6 Price Target By Benzinga Newsdesk March 17, 8:14 AM Wedbush analyst Robert Driscoll reiterates Geron (NASDAQ:GERN) with a Outperform and maintains $6 price target. GERN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Oppenheimer Reiterates Outperform on Microvast Holdings, Maintains $8 Price Target By Benzinga Newsdesk March 17, 8:08 AM Oppenheimer analyst Colin Rusch reiterates Microvast Holdings (NASDAQ:MVST) with a Outperform and maintains $8 price target. MVST
Read More 1 minute read Analyst Ratings News Price Target Reiteration Oppenheimer Reiterates Outperform on Five Below, Maintains $235 Price Target By Benzinga Newsdesk March 17, 8:06 AM Oppenheimer analyst Brian Nagel reiterates Five Below (NASDAQ:FIVE) with a Outperform and maintains $235 price target. FIVE
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on TerrAscend, Announces $1.75 Price Target By Benzinga Newsdesk March 17, 6:44 AM Needham analyst Matt McGinley reiterates TerrAscend (OTC:TRSSF) with a Buy and announces $1.75 price target. TRSSF
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target By Benzinga Newsdesk March 17, 6:42 AM HC Wainwright & Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $16 price target. ACIU
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $22 Price Target By Benzinga Newsdesk March 17, 6:38 AM HC Wainwright & Co. analyst Robert Burns reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $22 price target. IKNA
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target By Benzinga Newsdesk March 17, 6:34 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target. ARMP
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $14 Price Target By Benzinga Newsdesk March 17, 6:31 AM HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $14 price target. ACXP
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on TFF Pharmaceuticals, Maintains $22 Price Target By Benzinga Newsdesk March 17, 6:30 AM HC Wainwright & Co. analyst Vernon Bernardino reiterates TFF Pharmaceuticals (NASDAQ:TFFP) with a Buy and maintains $22 price target. TFFP